Drug Database
Back to search

Switzerland· 48313027

Actilyse 20mg, Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung

A alteplase product containing alteplasum adnr, registered in Switzerland by Boehringer Ingelheim (Schweiz) GmbH and dispensed under Swissmedic category B. The same ATC class is registered in 14 of our 19 countries.

Cat B (Swissmedic)ATC B01AD02

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedActilyse 20mg, Pulver und Lösungsmitt…ATCB01AD02REGISTER NO.48313027PACKS LISTED0CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about alteplasum adnrAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Alteplase is registered in 14 of 19 countries.

Countries holding a registration under ATC B01AD02 (alteplase), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 8 of them publish a price we can compare per daily dose
Search alteplase products by name

Alteplase · ATC B01AD02

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of alteplase costs, country by country.

Normalised to the WHO defined daily dose (0.1 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Alteplase · price per daily dose (0.1 g)

USD · FX 28 Sept 2026

  • FI Finland$2204.37
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Swissmedic (Switzerland)
Active substance
alteplasum ADNr
Manufacturer
Boehringer Ingelheim (Schweiz) GmbH
Country
Switzerland (CH)
ATC code
B01AD02
ATC class
Alteplase
Defined daily dose
0.1 g, P
Swissmedic category
B
Reimbursed
No
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

146 interactions on record for alteplase.

Graded by severity as the source publishes them — 49 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check alteplase against other medicinesHow interaction checks work

Alteplase · interactions on record

146 records

  • 49 severe
  • 97 moderate

Most severe, free to view

  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • HeparinB01AB01severe
  • DalteparinB01AB04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Alteplase in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All alteplase products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Actilyse, Actilyse Cathflo
  • Belgium · Actilyse, Actilyse Cathflo
  • Bulgaria · Актилизе
  • Cyprus · Actilyse, Actilyse Cathflo
  • Czechia · Actilyse
  • Germany · Actilyse, Actilyse Cathflo
  • Denmark · Actilyse
  • Estonia · Actilyse
  • Spain · Actilyse
  • Finland · Actilyse
  • France · Actilyse
  • United Kingdom (Northern Ireland) · Actilyse, Actilyse Cathflo
  • Greece · Actilyse, Actilyse Cathflo
  • Croatia · Actilyse
  • Hungary · Actilyse
  • Ireland · Actilyse, Actilyse Cathflo
  • Iceland · Actilyse
  • Italy · Actilyse
  • Lithuania · Actilyse
  • Luxembourg · Actilyse, Actilyse Cathflo
  • Latvia · Actilyse
  • Malta · Actilyse
  • Netherlands · Actilyse, Actilyse Cathflo
  • Norway · Actilyse
  • Poland · Actilyse 10, Actilyse 20
  • Portugal · Actilyse, Actilyse Cathflo
  • Romania · Actilyse
  • Sweden · Actilyse
  • Slovenia · Actilyse, Actilyse Cathflo
  • Slovakia · Actilyse

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/efe019ec-5424-4dc1-8634-6eb5eaa3cd35
GET /v1/drugs/efe019ec-5424-4dc1-8634-6eb5eaa3cd35?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{}
API referenceMCP serverPlans

See everything about alteplase.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console